Lepu Biopharma , Ltd. Current Assets

Lepu Biopharma , Ltd. (2157.HK) currently reports a current assets of $1.2B as of June 2026. That compares with $700M in the prior-year period — up 65.0% year over year. Use the charts on this page to explore Lepu Biopharma , Ltd.'s current assets history and peer comparisons.

Lepu Biopharma , Ltd.'s current assets increased from $700M to $1.2B — a 65.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lepu Biopharma , Ltd. reported $1.2B in current assets as of June 2026. That compares with $700M in the prior-year period — up 65.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $1.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lepu Biopharma , Ltd., and consider following 2157.HK for alerts when major investors trade the stock.

Lepu Biopharma , Ltd. is classified in the Healthcare sector. On current assets, it currently shows $1.2B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 2157.HK with unrelated industries.